Clinical Trials Logo

Alkalosis clinical trials

View clinical trials related to Alkalosis.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT06013189 Recruiting - Clinical trials for Optimal Sweep Gas Flow

Re-Adjustment of Sweep Gas Flow to the During the Rewarming Period of the Cardiopulmonary Bypass

Start date: August 7, 2023
Phase:
Study type: Observational [Patient Registry]

The investigators designed this prospective observational study with the theory that alkalosis caused by decreased CO2 solubility due to temperature increase during the rewarming period of the Cardiopulmonary Bypass could be prevented by reducing the sweep gas flow during the rewarming period.

NCT ID: NCT03966664 Recruiting - Sepsis Clinical Trials

Determination of the Dissociation Constant (Ka) of Plasma and Whole Blood in Septic Patients

ENTERPRISE
Start date: June 3, 2019
Phase:
Study type: Observational

Alterations of acid-base equilibrium are very common in critically ill patients and understanding their pathophysiology can be important to improve clinical treatment.

NCT ID: NCT03847571 Recruiting - Bartter Syndrome Clinical Trials

Acetazolamide (AZ) for Management of Alkalosis in Bartter Syndrome

AZ
Start date: January 10, 2019
Phase:
Study type: Observational

In this prospective controlled cross over clinical trial, the investigators aim to evaluate the efficacy and safety of acetazolamide for the management of metabolic alkalosis in children with Bartter syndrome. Urine and blood electrolytes will be measured before and after acetazolamide treatment. The primary end point is a change in polyuria, hypokalemia, and metabolic alkalosis.

NCT ID: NCT03496311 Recruiting - Pregnancy Clinical Trials

Cerebrospinal Acid-base in Pregnant and Non-pregnant Fertile Women

Start date: April 13, 2018
Phase:
Study type: Observational

The third trimester of pregnancy is typically characterized by the development of a marked respiratory alkalosis. The possible role of pregnancy-induced variations of cerebrospinal fluid (CSF) acid-base characteristics on the development of hypocapnic alkalosis is still unknown. Aim of this study is to characterize, according to Stewart's approach, the acid-base equilibrium of CSF and arterial plasma of pregnant women and compare the results with data obtained from fertile, non-pregnant women.

NCT ID: NCT03309423 Recruiting - Sepsis Clinical Trials

Is Venous to Arterial Conversion (v-TAC) of Blood Gas Reliable in Critical Ill Patients in the ICU?

Start date: October 9, 2017
Phase: N/A
Study type: Observational

Objective: Arterial blood gas (ABG) is essential in the clinical assessment of potential acutely ill patients venous to arterial conversion (v-TAC), a mathematical method, has recently been developed to convert peripheral venous blood gas (VBG) values to arterialized VBG (aVBG) values. The aim of this study is to test the reliability of aVBG compared to ABG in an intensive care unit (ICU) setting. Method: Consecutive patients admitted to the ICU with pH values <7,35 or >7,45 are included in this study. Paired ABG and aVBG samples are drawn from patients via arterial catheter, central venous catheter and/or peripheral venous catheter and compared.

NCT ID: NCT01131377 Recruiting - Ventilator Weaning Clinical Trials

Acetazolamide Facilitates Ventilator Weaning

Start date: May 2010
Phase: N/A
Study type: Interventional

Metabolic alkalosis(MA) is common metabolic disorder in ICU setting. MA could be cause of weaning failure or delay by depression of respiratory center. The purpose of this study is to evaluate that correction of MA by administration of acetazolamide facilitates weaning of mechanical ventilation.

NCT ID: NCT00163852 Recruiting - Cystic Fibrosis Clinical Trials

Treatment of Metabolic Alkalosis in Acute Exacerbations of Cystic Fibrosis

Start date: February 2004
Phase: Phase 2/Phase 3
Study type: Interventional

Adult cystic fibrosis (CF) patients admitted with an acute infection complicated by acid-base disturbance and decreased ventilation will be studied. They will receive salt replacement to correct the acid-base disturbance and possibly their ventilation. Assessment of symptoms (questionnaire), acid-base and electrolyte status (blood and urine tests) ventilation (overnight oxygen and carbon dioxide monitoring non-invasively) and sleep-wake pattern (actigraphy) will be carried out. Study hypothesis: Acute volume and electrolyte replacement corrects hypochloremic hypovolemic metabolic alkalosis and compensatory hypoventilation/ hypercapnia in acute exacerbations of cystic fibrosis.